Trademarkia Logo

Canada

C$
Trademark Search in Canada
MISCELLANEOUS DESIGN

View On IC.GC.CA

MISCELLANEOUS DESIGN
REGISTERED

on 14 Jul 2020

Last Applicant/ Owned by

NOVARTIS AG

4002 Basel

CH

Serial Number

1931744 filed on 21st Nov 2018

Registration Number

TMA1080463 registered on 14th Jul 2020

Registration expiry Date

14th Jul 2030

Correspondent Address

SMART & BIGGAR LP

SCOTIA PLAZA40 KING STREET WEST40th FLOORTORONTO

ONTARIO

CA

M5H3Y2

MISCELLANEOUS DESIGN

Trademark usage description

pharmaceutical preparations for the prevention and treatment of the central nervous system, namely, central nervous system infections, brain diseases, Read More

Vienna Information

24 . 15 . 21

Arrowheads -- Note: Not including arrowheads in the form of angles (26.3.23).Pointes de flèches -- Note: Non compris les pointes de flèches en forme d'angles (26.3.23).

26 . 3 . 4

Several triangles, juxtaposed, joined or intersectingPlusieurs triangles, juxtaposés, accolés ou se coupant

26 . 3 . 5

Triangles pointing downwardsTriangles avec la pointe en bas

26 . 3 . 7

Triangular figures with one or more truncated or rounded anglesFigures triangulaires à un ou plusieurs angles coupés ou arrondis

26 . 3 . 24

Triangles with dark surfaces or parts of surfacesTriangles avec surface ou partie de la surface foncée

Classification Information

Class [005]
Pharmaceutical preparations for the prevention and treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for the prevention and treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; anti-inflammatories; pharmaceutical preparations for the prevention and treatment of disorders of the respiratory system; pharmaceutical preparations for the prevention and treatment of disorders of the musculo-skeletal system, namely, connective tissue disease, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the prevention and treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in hematology, namely for the treatment of blood disorders; pharmaceutical preparations for use in tissue and organ transplantation; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for prevention and treatment of ocular disorders and diseases; anti-infectives, anti-bacterials, antivirals, anti-biotics, systemic and topical anti-fungals

Classification kind code

11

Mark Details

Serial Number

1931744

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 190
on 5th Feb 2020		Registration Pending
Submitted for opposition 191
on 5th Feb 2020		Registration Fee Notice Sent
Submitted for opposition 42
on 13th Nov 2019		Advertised
Submitted for opposition 22
on 23rd Oct 2019		Search Recorded
Submitted for opposition 26
on 23rd Oct 2019		Approved
Submitted for opposition 27
on 23rd Oct 2019		Approval Notice Sent
Submitted for opposition 67
on 11th Sept 2019		Agent Name Changed
Submitted for opposition 31
on 28th Nov 2018		Formalized
Submitted for opposition 1
on 22nd Nov 2018		Created
Submitted for opposition 30
on 21st Nov 2018		Filed